BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29121047)

  • 1. Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.
    Li R; Zhang Y; Yuan Y; Lin Q; Dai J; Xu R; Hu X; Han M
    PLoS One; 2017; 12(11):e0187390. PubMed ID: 29121047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
    de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
    Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.
    Moustakis C; Blanck O; Ebrahimi Tazehmahalleh F; Ka Heng Chan M; Ernst I; Krieger T; Duma MN; Oechsner M; Ganswindt U; Heinz C; Alheit H; Blank H; Nestle U; Wiehle R; Kornhuber C; Ostheimer C; Petersen C; Pollul G; Baus W; Altenstein G; Beckers E; Jurianz K; Sterzing F; Kretschmer M; Seegenschmiedt H; Maass T; Droege S; Wolf U; Schoeffler J; Haverkamp U; Eich HT; Guckenberger M
    Strahlenther Onkol; 2017 Oct; 193(10):780-790. PubMed ID: 28567503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive dosimetric study on switching from a Type-B to a Type-C dose algorithm for modern lung SBRT.
    Zhou C; Bennion N; Ma R; Liang X; Wang S; Zvolanek K; Hyun M; Li X; Zhou S; Zhen W; Lin C; Wahl A; Zheng D
    Radiat Oncol; 2017 May; 12(1):80. PubMed ID: 28476138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison of peripheral NSCLC SBRT using Acuros XB and AAA calculation algorithms.
    Ong CCH; Ang KW; Soh RCX; Tin KM; Yap JHH; Lee JCL; Bragg CM
    Med Dosim; 2017 Autumn; 42(3):216-222. PubMed ID: 28711478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer.
    Merna C; Rwigema JC; Cao M; Wang PC; Kishan AU; Michailian A; Lamb J; Sheng K; Agazaryan N; Low DA; Kupelian P; Steinberg ML; Lee P
    Med Dosim; 2016; 41(1):87-91. PubMed ID: 26755076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): The effect on target coverage, organ-at-risk doses, and dose conformity.
    Franks KN; Purdie TG; Dawson LA; Bezjak A; Jaffray DA; Bissonnette JP
    Med Dosim; 2010; 35(2):101-7. PubMed ID: 19931021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.
    Shang H; Pu Y; Wang Y
    Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dosimetry evaluation of 3D printing non-coplanar template-assisted CT-guided 125I seed stereotactic ablation brachytherapy for pelvic recurrent rectal cancer after external beam radiotherapy.
    Wang H; Peng R; Li X; Wang Y; Jiang Y; Ji Z; Guo F; Tian S; Sun H; Fan J; Wang J
    J Radiat Res; 2021 May; 62(3):473-482. PubMed ID: 33616168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer.
    Bai X; Shan G; Chen M; Wang B
    Biomed Eng Online; 2019 Oct; 18(1):101. PubMed ID: 31619263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.
    Shaverdian N; Tenn S; Veruttipong D; Wang J; Hegde J; Lee C; Cao M; Agazaryan N; Steinberg M; Kupelian P; Lee P
    Br J Radiol; 2016; 89(1059):20150963. PubMed ID: 26764282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
    Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
    Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumferential or sectored beam arrangements for stereotactic body radiation therapy (SBRT) of primary lung tumors: effect on target and normal-structure dose-volume metrics.
    Rosenberg MW; Kato CM; Carson KM; Matsunaga NM; Arao RF; Doss EJ; McCracken CL; Meng LZ; Chen Y; Laub WU; Fuss M; Tanyi JA
    Med Dosim; 2013; 38(4):407-12. PubMed ID: 23810414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric analysis between carbon ion radiotherapy and stereotactic body radiotherapy in stage I lung cancer.
    Ebara T; Shimada H; Kawamura H; Shirai K; Saito J; Kawashima M; Tashiro M; Ohno T; Kanai T; Nakano T
    Anticancer Res; 2014 Sep; 34(9):5099-104. PubMed ID: 25202098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric evaluation of compensator intensity modulation-based stereotactic body radiotherapy for Stage I non-small-cell lung cancer.
    Tajima Y; Nakayama H; Itonaga T; Shiraishi S; Okubo M; Mikami R; Sugahara S; Tokuuye K
    Br J Radiol; 2015 Aug; 88(1052):20150122. PubMed ID: 25996577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3D printed template-assisted and computed tomography image-guided 125-iodine seed implantation for supraclavicular metastatic tumor: a dosimetric study].
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):506-511. PubMed ID: 28628155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.